Silvia Bione

Dr. Silvia Bione

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1994 in Nature Genetics
Verified
Journal Article
Closed access
SBSilvia Bione
Silvia Bione
EMElena Maestrini
Elena Maestrini
SRStefano Rivella
Stefano Rivella
MMMita Mancini
Mita Mancini
SRStefano Regis
Stefano Regis
DTDaniela Toniolo
Daniela Toniolo

1 April 1996 in Nature Genetics
Verified
Journal Article
Closed access
SBSilvia Bione
Silvia Bione
PDPatrizia D'Adamo
Patrizia D'Adamo
EMElena Maestrini
Elena Maestrini
AGAgi K. Gedeon
Agi K. Gedeon
PBPieter A. Bolhuis
Pieter A. Bolhuis
DTDaniela Toniolo
Daniela Toniolo

1 April 2000 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MBMarina Raffaele di Barletta
Marina Raffaele di Barletta
EREnzo Ricci
Enzo Ricci
GGGiuliana Galluzzi
Giuliana Galluzzi
PTPietro Tonali
Pietro Tonali
MMMarina Mora
Marina Mora
DTDaniela Toniolo
Daniela Toniolo

1 March 1998 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SBSilvia Bione
Silvia Bione
CSCinzia Sala
Cinzia Sala
CMChiara Manzini
Chiara Manzini
GAGiulia Arrigo
Giulia Arrigo
OZorsetta zuffardi
orsetta zuffardi
DTDaniela Toniolo
Daniela Toniolo

1 October 1997 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PDPatrizia D'ADamo
Patrizia D'ADamo
LFLucia Fassone
Lucia Fassone
AGAgi Gedeon
Agi Gedeon
EJEmiel A.M. Janssen
Emiel A.M. Janssen
SBSilvia Bione
Silvia Bione
DTDaniela Toniolo
Daniela Toniolo

16 December 2005 in Human Reproduction
Verified
Journal Article
Open access
PDF file
BBBeatrice Bodega
Beatrice Bodega
SBSilvia Bione
Silvia Bione
LDL. Dalprà
L. Dalprà
DTD. Toniolo
D. Toniolo
FOF. Ornaghi
F. Ornaghi
AMAnna Marozzi
Anna Marozzi
BACKGROUND: Studies attempting to precisely define the range of fragile mental retardation 1 (FMR1) expansions and its inf luence in premature ovarian failure (POF) manifestation are partially lacking. To this aim, we evaluated a large cohort of POF patients for the size and, in selected cases, for the sequence of the CGG expansion. Furthermore, the correlation between POF and X-inactivation was investigated in FRAXA families. METHODS: By fluorescent PCR, 190 POF and 200 control women were sized for the CGG tract; some subjects were also characterized by sequencing and for the FMR1 activation ratio. RESULTS AND CONCLUSION: We found a significant association (19/190, 10%, P < 1 × 10−6) between POF and FMR1 premutation (range 63–163 repeats) and a significant enrichment (9/190, 4.7%, P = 0.021) of POF carriers of intermediate expansions (range 41–58 repeats). Interestingly, intermediate alleles were entirely composed of CGG repeats. Furthermore, the analysis of three pairs of siblings with similar FMR1 expansions and discordant for the POF phenotype showed a direct correlation between the expression of the intermediate/premutated allele and POF manifestation. The results obtained strengthen the correlation between FMR1 expansion and POF and suggest that the manifestation of the ovarian dysfunction could be influenced both by the pattern of interruption of the CGG repeat and by X-inactivation.